logo
Plus   Neg
Share
Email

J Sainsbury Restates 2018/19 Financial Statements; Cuts FY Pre-tax Profit

J Sainsbury plc (SBRY.L) reported that restated underlying profit before tax for 2018/19 reduced by 34 million pounds and statutory profit before tax reduced by 37 million pounds, following adoption of new IFRS 16 lease standard.

Annual underlying profit before tax reduced to 601 million pounds from the 635 million pounds, and statutory profit before tax reduced to 202 million pounds from 239 million pounds.

The restatement comprised 747 million pounds reduction in rent, 470 million pounds increase in depreciation, 323 million pounds increase in underlying net finance costs and 12 million pounds reduction in other costs.

As previously indicated, the company is adopting the fully retrospective approach to the new IFRS 16 lease standard, effective for the Group for the 52 weeks ending 7 March 2020.

IFRS 16 will have no economic effect on the business or cash. But, it does impact the way assets, liabilities and the income statement are presented, the company said in a statement.

The company noted that its first Financial Statements to be prepared under IFRS 16 will be Interims 2019/20, to be reported on 7 November 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT